Compatibility evaluation and biological basis of Evodia Fructus Recipe based on combination of clinical disease and syndrome

Fifth Medical Center of PLA General Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•? Age 18 to 65 years old, male or female;
•? Western medicine diagnosed as chronic non-atrophic gastritis;
•? TCM syndrome differentiation is the liver-fire invading stomach syndrome or liver-stomach deficiency-cold syndrome;
•? Subjects of childbearing age who voluntarily take effective contraceptive measures during the trial;
•? Voluntarily signed the informed consent.

•? Gastroscopy with esophageal disease, peptic ulcer, tumor, bleeding lesions;
•? Combined with severe dysplasia of gastric mucosa and pathological diagnosis of suspected malignant transformation;
•? Patients with autoimmune gastritis were excluded by serum gastrin, vitamin B12 levels and related autoantibodies (anti-parietal cell antibodies and anti-intrinsic factor antibodies);
•? Have serious primary heart, liver, lung, kidney, blood or serious diseases that affect their survival, such as tumors, AIDS or coagulation disorders;
•? Laboratory examination: Scr>N (N is the upper limit of normal value); ALT, AST>N; white blood cells <3.0×109/L;
•? Allergic constitution, such as those who are allergic to drugs or food; or those who are known to be allergic to research drugs;
•? Patients with alcoholism and drug dependence, with a history of epilepsy or with mental disorders;
•? Pregnant, lactating women or those planning to become pregnant;
•? Those who have participated in or are participating in other clinical trials within 3 months;
•? Other patients deemed unsuitable for the study by the investigator.

发起方

Fifth Medical Center of PLA General Hospital